The Middle East and Africa biomarker-based immunoassays market size was estimated at USD 165.4 million in 2024 and is projected to reach USD 234.2 million by 2033, growing at a CAGR of 3.8% from 2025 to 2033. The market growth is fueled by the rising global burden of chronic diseases suc... Read More »
August 2025The U.S. hereditary cancer testing market was estimated at USD 1.93 billion in 2024 and is projected to reach USD 5.76 billion by 2033, growing at a CAGR of 13.32% from 2025 to 2033. The U.S. hereditary cancer testing market is driven by growing awareness of inherited cancer risks, with ... Read More »
August 2025The U.S. biomarker-based immunoassays market size was estimated at USD 2.17 billion in 2024 and is projected to reach USD 4.28 billion by 2033, growing at a CAGR of 7.95% from 2025 to 2033. The market growth is fueled by the rising U.S. burden of chronic diseases such as c... Read More »
August 2025The global biomarker-based immunoassays market size was valued at USD 5.15 billion in 2024 and is expected to reach USD 8.33 billion by 2033, growing at a CAGR of 5.4% from 2025 to 2033. The market growth is fueled by the rising global burden of chronic diseases such as ca... Read More »
August 2025The Middle East & Africa blood-based biomarker for Alzheimer’s disease diagnostics market size was estimated at USD 6.22 million in 2024 and is expected to reach USD 13.11 million by 2033, growing at a CAGR of 9.77% from 2025 to 2033. Rising awareness of neurodegenerative disea... Read More »
August 2025The global blood-based biomarker for Alzheimer’s disease diagnostics market size was estimated at USD 139.69 million in 2024 and is expected to reach USD 429.31 million by 2033, growing at a CAGR of 15.07% from 2025 to 2033. A pivotal catalyst was the U.S. FDA’s May 16, 2025,... Read More »
August 2025The U.S. blood-based biomarker for alzheimer’s disease diagnostics market size was estimated at USD 59.64 million in 2024 and is expected to grow at a CAGR of 14.60% from 2025 to 2033. This growth is fueled by rising Alzheimer’s prevalence, increasing demand for non-invasive ... Read More »
August 2025The Middle East liver cancer diagnostics market size was estimated at USD 268.10 million in 2024 and is projected to reach USD 466.42 million by 2033, growing at a CAGR of 6.35% from 2025 to 2033. The ME liver cancer diagnostics market is primarily driven by the high prevalence of HBV an... Read More »
August 2025The Middle East hereditary cancer testing market size was estimated at USD 66.25 million in 2024 and is projected to reach USD 169.10 million by 2033, growing at a CAGR of 11.28% from 2025 to 2033. The market is expanding rapidly, driven by high cancer prevalence, consanguinity, and nati... Read More »
August 2025The U.S. liver cancer diagnostics market size was estimated at USD 3.14 billion in 2024 and is projected to reach USD 4.44 billion by 2033, growing at a CAGR of 3.74% from 2025 to 2033. In the United States, liver and intrahepatic bile duct cancers remain a major health burden, with an e... Read More »
August 2025The global hereditary cancer testing market size was estimated at USD 4.67 billion in 2024 and is projected to reach USD 14.45 billion by 2033, growing at a CAGR of 13.76% from 2025 to 2033. The demand for hereditary cancer testing is increasinyg due to technological advancements in gene... Read More »
August 2025The global liver disease diagnostics market size was valued at USD 37.85 billion in 2024 and is expected to reach USD 66.40 billion by 2033, growing at a CAGR of 6.39% from 2025 to 2033. This market centers on innovative diagnostic tools that enable early detection and monitoring of live... Read More »
August 2025The U.S. oncology based molecular diagnostics market size was estimated at USD 1.49 billion in 2024 and is expected to grow at a CAGR of 5.2% from 2025 to 2033. Key market driving factors for the market include the rapid evolution of sequencing technologies (e.g., shift from Sanger to NG... Read More »
August 2025The global hepatic fibrosis biomarkers market size was estimated at USD 423.51 million in 2024 and is projected to reach USD 2,291.73 million by 2033, growing at a CAGR of 20.01% from 2025 to 2033. The rising prevalence of NASH, a consequence of obesity, sedentary lifestyles, and metabol... Read More »
August 2025The Middle East STD diagnostics market size was estimated at USD 216.56 million in 2024 and is projected to reach USD 390.96 million by 2033, growing at a CAGR of 6.75% from 2025 to 2033. Rising incidence of sexually transmitted infections such as HIV, syphilis, gonorrhea, and chlamydia,... Read More »
August 2025The U.S. employer and workplace drug testing market size was estimated at USD 2.57 billion in 2024 and is projected to reach USD 4.01 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. The market is primarily driven by stringent workplace safety regulations, growing awareness ... Read More »
August 2025The global employer and workplace drug testing market size was estimated at USD 6,105.1 million in 2024 and is projected to reach USD 9,089.9 million by 2033, growing at a CAGR of 4.6% from 2025 to 2033. This market focuses on detecting the presence of illicit drugs and controlled substa... Read More »
August 2025The global transaminase test market size was estimated at USD 4.10 billion in 2024 and is projected to reach USD 7.81 billion by 2033, growing at a CAGR of 7.54% from 2025 to 2033. This market centers on rapid, accurate diagnostic platforms, such as AST (Aspartate Transaminase) and GOT (... Read More »
August 2025The Middle East human papilloma virus testing market size was estimated at USD 60.02 million in 2024 and is projected to reach USD 203.37 million by 2033, growing at a CAGR of 14.80% from 2025 to 2033. Low HPV vaccine awareness and acceptance in the Middle East, driven by limited inclusi... Read More »
August 2025The U.S. human papillomavirus testing market size was estimated at USD 638.37 million in 2024 and is projected to grow at a CAGR of around 13.56% from 2025 to 2033. The market growth is propelled by evolving clinical guidelines, technological innovation, and growing emphasis on preventiv... Read More »
August 2025